Revenue
2018
2019
2020
2021
2022
2023
2024
2025
REPLIGEN CORP (RGEN)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 · Dec 31 | 2011 · Mar 31 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $738.3M | $634.4M | $632.4M | $801.5M | $670.5M | $366.3M | $270.2M | $194.0M | $141.2M | $104.5M | $83.5M | $63.5M | $68.2M | $62.3M | — | $27.3M | $21.0M |
| Research & development | $54.2M | $43.2M | $42.7M | $43.9M | $34.3M | $20.2M | $19.4M | $15.8M | $8.7M | $7.4M | $5.7M | $5.6M | $7.3M | $10.5M | — | $12.5M | $14.2M |
| Operating income | $55.2M | −$35.1M | $47.7M | $224.7M | $167.2M | $69.8M | $36.1M | $26.0M | $14.0M | $16.0M | $13.8M | $10.7M | $22.9M | $11.1M | — | −$374,071 | −$5.8M |
| EBITDAderived | $133.9M | $34.6M | $116.3M | $275.7M | $205.7M | $96.9M | $57.0M | $41.8M | $24.5M | $21.3M | $18.4M | $14.7M | $26.0M | $14.6M | — | $1.3M | −$4.4M |
| Net income | $48.9M | −$25.5M | $35.6M | $186.0M | $128.3M | $59.9M | $21.4M | $16.6M | $28.4M | $11.7M | $9.3M | $8.2M | $16.1M | $14.2M | −$1.6M | −$43,509 | −$4.1M |
| Basic EPSper diluted share | $0.87 | -$0.46 | $0.64 | $3.35 | $2.33 | $1.14 | $0.44 | $0.38 | $0.74 | $0.35 | $0.28 | $0.25 | $0.51 | $0.46 | — | $0.00 | -$0.13 |
| Diluted EPSper diluted share | $0.86 | -$0.46 | $0.63 | $3.24 | $2.24 | $1.11 | $0.44 | $0.37 | $0.72 | $0.34 | $0.28 | $0.25 | $0.50 | $0.45 | — | $0.00 | -$0.13 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 25, 2026Form 4 · 10b5-1 | Garland Jason KCFO | SellCommon Stock | 733 | $145.00 | $106.3K | 19.4K |
| Apr 21, 2026Form 4 · 10b5-1 | Loeillot OlivierChief Executive Officer | SellCommon Stock | 3.8K | $140.00 | $536.5K | 54.2K |
| Dec 17, 2025Form 4 | DAWES KAREN ADirector | SellCommon Stock | 275 | $161.00 | $44.3K | 91.8K |
| Nov 25, 2025Form 4 · 10b5-1 | Loeillot OlivierChief Executive Officer | SellCommon Stock | 7.0K | $170.00 | $1.20M | 35.9K |
| Nov 18, 2025Form 4 | Bylund JamesChief Operating Officer | SellCommon Stock | 2.2K | $151.21 | $331.3K | 21.5K |